Abstract
A 38-year-old man developed idiopathic thrombocytopenic purpura (ITP) 8 months following allogeneic BMT while being treated for cGVHD with corticosteroids and tacrolimus (FK506). He received two courses of high-dose intravenous immunoglobulin (IvIG) which resulted in transient improvement. A single dose of intravenous anti-D immunoglobulin induced a durable response. Anti-D immunoglobulin is better tolerated, less complicated to administer, and less expensive than a course of IvIG.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, S., Churchill, W., Konugres, A. et al. Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation – treatment with anti-D immunoglobulin. Bone Marrow Transplant 19, 173–174 (1997). https://doi.org/10.1038/sj.bmt.1700634
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700634
Keywords
This article is cited by
-
Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient
Bone Marrow Transplantation (2006)
-
Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT
Bone Marrow Transplantation (2001)
-
Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients
Bone Marrow Transplantation (2000)